FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136041718> ?p ?o ?g. }

• W3136041718 endingPage "120763" @default.
• W3136041718 startingPage "120763" @default.
• W3136041718 abstract "Nanomaterials have attracted increased attention because of their excellent drug-carrying capacity. However, these nanomaterials are rarely used in the treatment of metabolic diseases. Liraglutide, a glucagon-like peptide-1 receptor agonist, has been widely used in the treatment of type 2 diabetes mellitus (T2DM). Furthermore, fibroblast growth factor 21 (FGF-21) has been found to improve glucose metabolism and insulin resistance (IR). To investigate whether these two molecules have synergistic effects in vivo, we developed a novel drug delivery system using amino-functionalized and embedded dual-mesoporous silica nanoparticles (N-EDMSNs) to simultaneously carry liraglutide and FGF-21, and observed their biological effects. The resultant N-EDMSNs possessed unique hierarchical porous structures consisting of open large pores (>10 nm) and small mesopores (~2.5 nm) in the silica framework, highly positively charged surfaces and good disperisity in aqueous solution. We found that N-EDMSNs had a high loading capacity for exogenous genes and low toxicity to Hepa1-6 cells. Moreover, N-EDMSNs can simultaneously carry FGF-21 plasmids and liraglutide and successfully transfect them into Hepa1-6 cells. The transfection efficiency of N-EDMSNs was higher than that of Lipofectamine 2000 in vitro. In mice experiments, N-EDMSNs/pFGF21 treatment resulted in higher FGF-21 expression in the liver than pFGF21 treatment with hydrodynamic delivery. Compared with both pFGF21 and liraglutide, N-EDMSNs/pFGF21/Lira treatment significantly reduced the food intake, body weight, and blood glucose; increased the energy expenditure and improved hepatic IR in high-fat diet (HFD)-fed mice. Our results demonstrated that the biological effects of N-EDMSNs/pFGF21/Lira complexes were better than those of pFGF21 combined with liraglutide in vivo." @default.
• W3136041718 created "2021-03-29" @default.
• W3136041718 creator A5000093728 @default.
• W3136041718 creator A5026856159 @default.
• W3136041718 creator A5028776321 @default.
• W3136041718 creator A5044967169 @default.
• W3136041718 creator A5051307940 @default.
• W3136041718 creator A5058079930 @default.
• W3136041718 creator A5084853102 @default.
• W3136041718 date "2021-04-01" @default.
• W3136041718 modified "2023-10-16" @default.
• W3136041718 title "Effective and safe delivery of GLP-1AR and FGF-21 plasmids using amino-functionalized dual-mesoporous silica nanoparticles in vitro and in vivo" @default.
• W3136041718 cites W1151480401 @default.
• W3136041718 cites W1482009781 @default.
• W3136041718 cites W1967597651 @default.
• W3136041718 cites W1981199702 @default.
• W3136041718 cites W1982531307 @default.
• W3136041718 cites W1988857777 @default.
• W3136041718 cites W1989584881 @default.
• W3136041718 cites W1993235686 @default.
• W3136041718 cites W2001391476 @default.
• W3136041718 cites W2001929038 @default.
• W3136041718 cites W2008411184 @default.
• W3136041718 cites W2013082477 @default.
• W3136041718 cites W2022252635 @default.
• W3136041718 cites W2049435689 @default.
• W3136041718 cites W2052615976 @default.
• W3136041718 cites W2054151200 @default.
• W3136041718 cites W2074353166 @default.
• W3136041718 cites W2080128749 @default.
• W3136041718 cites W2087340989 @default.
• W3136041718 cites W2108969731 @default.
• W3136041718 cites W2111653877 @default.
• W3136041718 cites W2119351413 @default.
• W3136041718 cites W2130266732 @default.
• W3136041718 cites W2131622156 @default.
• W3136041718 cites W2143014102 @default.
• W3136041718 cites W2145044799 @default.
• W3136041718 cites W2171010870 @default.
• W3136041718 cites W2331603672 @default.
• W3136041718 cites W2460297287 @default.
• W3136041718 cites W2592740738 @default.
• W3136041718 cites W2595309464 @default.
• W3136041718 cites W2620919920 @default.
• W3136041718 cites W2746455523 @default.
• W3136041718 cites W2771679766 @default.
• W3136041718 cites W2799602777 @default.
• W3136041718 cites W2893215169 @default.
• W3136041718 cites W2911081366 @default.
• W3136041718 cites W2912766252 @default.
• W3136041718 cites W2913539314 @default.
• W3136041718 cites W2920406506 @default.
• W3136041718 cites W2923461331 @default.
• W3136041718 cites W2955432327 @default.
• W3136041718 cites W2959504794 @default.
• W3136041718 cites W3016185486 @default.
• W3136041718 doi "https://doi.org/10.1016/j.biomaterials.2021.120763" @default.
• W3136041718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33780737" @default.
• W3136041718 hasPublicationYear "2021" @default.
• W3136041718 type Work @default.
• W3136041718 sameAs 3136041718 @default.
• W3136041718 citedByCount "12" @default.
• W3136041718 countsByYear W31360417182022 @default.
• W3136041718 countsByYear W31360417182023 @default.
• W3136041718 crossrefType "journal-article" @default.
• W3136041718 hasAuthorship W3136041718A5000093728 @default.
• W3136041718 hasAuthorship W3136041718A5026856159 @default.
• W3136041718 hasAuthorship W3136041718A5028776321 @default.
• W3136041718 hasAuthorship W3136041718A5044967169 @default.
• W3136041718 hasAuthorship W3136041718A5051307940 @default.
• W3136041718 hasAuthorship W3136041718A5058079930 @default.
• W3136041718 hasAuthorship W3136041718A5084853102 @default.
• W3136041718 hasConcept C104317684 @default.
• W3136041718 hasConcept C106646824 @default.
• W3136041718 hasConcept C12554922 @default.
• W3136041718 hasConcept C134018914 @default.
• W3136041718 hasConcept C150903083 @default.
• W3136041718 hasConcept C161790260 @default.
• W3136041718 hasConcept C170493617 @default.
• W3136041718 hasConcept C171250308 @default.
• W3136041718 hasConcept C185592680 @default.
• W3136041718 hasConcept C192562407 @default.
• W3136041718 hasConcept C207001950 @default.
• W3136041718 hasConcept C2777180221 @default.
• W3136041718 hasConcept C2777496208 @default.
• W3136041718 hasConcept C2779820397 @default.
• W3136041718 hasConcept C2781308992 @default.
• W3136041718 hasConcept C40767141 @default.
• W3136041718 hasConcept C49923114 @default.
• W3136041718 hasConcept C55493867 @default.
• W3136041718 hasConcept C555293320 @default.
• W3136041718 hasConcept C71924100 @default.
• W3136041718 hasConcept C74373430 @default.
• W3136041718 hasConcept C82776694 @default.
• W3136041718 hasConcept C86803240 @default.
• W3136041718 hasConcept C92087593 @default.
• W3136041718 hasConcept C98274493 @default.
• W3136041718 hasConceptScore W3136041718C104317684 @default.

• next